Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A ...
The drug discovery services market is expanding, driven by advancements in biotechnology, personalized medicine, and the increasing demand for efficient, cost-effective drug development solutions.” - ...
The VisionCyte platform leverages high resolution morphological profiling, high-throughput capabilities, and advanced AI ...
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
These solutions include AI agents that can speed clinical trials by reducing administrative burden, AI models that learn from biology instruments to advance drug discovery and digital pathology ...
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
Trials in China usually recruit patients faster than in the west because of the country’s large pool of people who have not ...
Associate Professor Qing Zhong shared insights on AI breakthroughs in proteomics and multiomics, challenges in data sharing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results